Search
for
Sort by
Research 31–60 of 403
- Keratin 17 in disease pathogenesis: from cancer to dermatoses
- Imbalance of T‐helper 17 and regulatory T cells in patients with alopecia areata
- An integrated model of alopecia areata biomarkers highlights both TH1 and TH2 upregulation
- Alopecia areata is characterized by dysregulation in systemic type 17 and type 2 cytokines, which may contribute to disease‐associated psychological morbidity
- Alarmin Cytokines as Central Regulators of Cutaneous Immunity
- Autoimmunity and autoimmune co-morbidities in psoriasis
- Altered Dermal Fibroblasts in Systemic Sclerosis Display Podoplanin and CD90
- The Role of Serum Th1, Th2, and Th17 Cytokines in Patients with Alopecia Areata: Clinical Implications
- Update on hidradenitis suppurativa: connecting the tracts
- Inflammatory and Anti-Inflammatory Parameters in PCOS Patients Depending on Body Mass Index: A Case-Control Study
- A novel therapeutic paradigm for patients with extensive alopecia areata
- iNKT cells ameliorate human autoimmunity: Lessons from alopecia areata
- New developments in the molecular treatment of ichthyosis: review of the literature
- Alopecia Diffusa while Using Interleukin-17 Inhibitors against Psoriasis Vulgaris
- Epigallocatechin-3 Gallate Inhibits STAT-1/JAK2/IRF-1/HLA-DR/HLA-B and Reduces CD8 MKG2D Lymphocytes of Alopecia Areata Patients
- Perforins Expression by Cutaneous Gamma Delta T Cells
- Pathological Mechanisms Involved in Epidermolysis Bullosa Simplex: Current Knowledge and Therapeutic Perspectives
- Dupilumab Alters Both the Bacterial and Fungal Skin Microbiomes of Patients with Atopic Dermatitis
- A Systematic Review of Keratinocyte Secretions: A Regenerative Perspective
- Spherical Nucleic Acids as Emerging Topical Therapeutics: A Focus on Psoriasis
- Pathophysiology of Alopecia Areata in the Pediatric Patient
- Yangyin Qingre Huoxue Method in Traditional Chinese Medicine Ameliorates Atherosclerosis in ApoE<sup>−/−</sup> Mice Suffering from High-Fat Diet and HSP65 Aggression
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Aberrant inflammasome activation as a driving force of human autoimmune skin disease
- Type 2 Cytokine–Dependent Skin Barrier Regulation in Personalized 2-Dimensional and 3-Dimensional Skin Models of Atopic Dermatitis: A Pilot Study
- Novel Quinazoline Derivative Induces Differentiation of Keratinocytes and Enhances Skin Barrier Functions against Th2 Cytokine-Mediated Signaling
- Current and future pharmacotherapy for alopecia areata
- γδ17 T cell-stromal networks modulate matrix composition and vascularity in foreign body response
- Appearance of alopecia areata during treatment with tildrakizumab for severe palmoplantar psoriasis
- Healthy individuals genetically at-risk for the development of Pemphigus vulgaris or Alopecia areata share disease-like cytokine dysregulation